Sponsors (14)
The bill aims to improve emergency overdose diagnosis and support hospitals with federal guidance and training insights, but does so at the cost of new implementation expenses, added privacy burdens, and the risk of routine testing without clear benefit that could undermine patient trust.
Patients who experience overdoses (including those with chronic conditions and substance use disorders) may receive clearer and potentially more accurate diagnosis and immediate care decisions if emergency departments adopt routine fentanyl testing.
Hospitals and ED clinicians would receive federal guidance and identified resources to implement testing, reducing uncertainty and lowering implementation barriers and costs for providers.
The required study will identify training needs and implementation barriers, enabling targeted staff training that could improve ED response to overdoses.
Hospitals and emergency departments, especially smaller or rural providers, may face new costs to implement routine fentanyl testing that could strain budgets and operational capacity.
Patients (including those with chronic conditions and substance use disorders) and providers may face additional privacy and HIPAA management burdens from creating and storing more protected health information.
If guidance leads to routine testing without clear clinical benefit in some cases, patients may experience unnecessary testing that could reduce trust in ED care or deter care-seeking.
Based on analysis of 4 sections of legislative text.
Directs HHS to study ED fentanyl testing during overdoses within 3 years and issue guidance within 9 months after the study on routine testing, test detection, outcomes, and federal resources.
Requires the HHS Secretary, working through the Assistant Secretary for Mental Health and Substance Use and coordinating with other federal stakeholders, to complete a study within three years on hospital emergency department practices and effects related to testing for fentanyl and fentanyl-related substances during patient overdoses. After the study, HHS must publish guidance within nine months about whether routine fentanyl testing should be used in EDs, how to inform clinicians which substances tests detect, expected effects on future overdose risk and outcomes, and federal resources for implementation.
Official title: Direct the Secretary of Health and Human Services to issue guidance on whether hospital emergency departments should implement fentanyl testing as a routine procedure for patients experiencing an overdose, and for other purposes.
Introduced March 10, 2025 by James E. Banks · Last progress March 24, 2026